Regeneron Pharmaceuticals, Inc. says some directors and officers are leaving, while new ones are being chosen and hired.

REGN · Regeneron Pharmaceuticals, Inc.

The AI's read

Tying the leaders’ pay to new product sales and drug development could focus them on growth. But the goals span 10 years, and existing products face more competition. The filing reports no new sales or drug results, so it does not change the company’s outlook.